A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/1997
10/28/1997	US5681835 Useful for treating osteoporosis
10/28/1997	US5681590 Dry mix formulation for bisphosphonic acids
10/28/1997	US5681353 Insertion into joints
10/28/1997	CA2136825C Quaternary nitrogen-containing phosphonate compounds, for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
10/23/1997	WO1997039032A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/23/1997	WO1997038986A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
10/23/1997	WO1997038704A1 Treatment of bone disorders with adrenomedullin
10/23/1997	WO1997034137A3 Methods of the identification of pharmaceutically active compounds
10/23/1997	DE19615812A1 Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation Pharmaceutical preparation for oral administration containing diphosphonic acids
10/23/1997	CA2252228A1 Treatment of bone disorders with adrenomedullin
10/23/1997	CA2224859A1 Ligand inhibitors of insulin-like growth factor binding proteins and methods of use therefor
10/22/1997	EP0802184A1 N-Benzyl-2-phenylindoles as estrogenic agents
10/21/1997	US5679716 Administering xanthohumol
10/16/1997	WO1997038104A1 Il-6 mutein
10/16/1997	WO1997038103A1 Il-6 mutein
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997038008A1 6-substituted amino-4-oxa-1-azabicyclo[3,2,0] heptan-7-one deriv atives as cysteine protease inhibitors
10/16/1997	WO1997038007A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997	WO1997037995A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997	WO1997037972A1 Novel vitamin d analogues
10/16/1997	WO1997037967A1 Calcilytic compounds
10/16/1997	WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	WO1997037655A1 αvβ3 ANTAGONISTS
10/16/1997	WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997	CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0\|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997	CA2251072A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997	CA2251017A1 .alpha.v.beta.3 antagonists
10/16/1997	CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997	CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/15/1997	EP0800530A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
10/15/1997	CN1162267A Methods and compositions for specific coagulation of vasculature
10/15/1997	CN1161846A Ointment for subsidence of swelling and relieving pain
10/14/1997	US5677319 Thiazole derivative
10/14/1997	CA2090423C Method of preparing diacetyl rhein
10/09/1997	WO1997037002A1 Promotion of regeneration of organized tissues
10/09/1997	WO1997036905A1 Diazepino-indoles as phosphodiesterase iv inhibitors
10/09/1997	WO1997036871A1 6-phenylpyridyl-2-amine derivatives
10/09/1997	WO1997036862A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
10/09/1997	WO1997036860A1 Cinnamic acid derivatives and their use as integrin antagonists
10/09/1997	WO1997036859A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
10/09/1997	WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof
10/09/1997	CA2250698A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
10/09/1997	CA2250690A1 Cinnamic acid derivatives and their use as integrin antagonists
10/09/1997	CA2250464A1 Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
10/09/1997	CA2248729A1 Promotion of regeneration of organized tissues
10/09/1997	CA2220407A1 Diazepino-indoles as phosphodiesterase iv inhibitors
10/08/1997	EP0799823A1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses
10/08/1997	EP0799311A1 Human chemokine beta-9
10/08/1997	CN1161225A Medical ointment for treating arthritis and hyperosteogeny
10/08/1997	CN1161216A Medicines for treating bone tuberculosis, osteomyelities medullitis and other swelling pain
10/07/1997	US5674887 Prevention of bone resorption
10/02/1997	WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997	WO1997035870A1 Growth factor htter36
10/02/1997	WO1997035856A1 Novel treatment for cns injuries
10/02/1997	WO1997035855A1 Novel treatment for cns injuries
10/02/1997	WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997	WO1997035849A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	WO1997035607A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997	WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997	WO1997035571A1 Benzothiophenes, formulations containing same, and methods
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2249999A1 1,2,4-triazine derivatives for the inhibition of protein glycosylation
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249212A1 Methods of tissue induction using a combination of bone morphogenetic protein and parathyroid hormone-related peptide
10/02/1997	CA2248318A1 Growth factor htter36
10/01/1997	EP0798001A2 Collagen containing preparations for strengthening bone
10/01/1997	EP0797444A1 Kit for osteoporosis treatment cycle
10/01/1997	CN1160566A Guyinggao ointment
10/01/1997	CN1160554A Marmot bone wine for curing rheumatism
09/1997
09/30/1997	US5672620 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
09/25/1997	WO1997035006A1 Human cell death-associated protein
09/25/1997	WO1997034929A1 Process for extraction of a growth factor complex
09/25/1997	WO1997034911A1 Apoptosis inducing molecule ii
09/25/1997	WO1997034895A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use
09/25/1997	WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action
09/25/1997	CA2249739A1 Novel n-7-heterocyclyl pyrrolo[2,3-d]pyridines and their use
09/25/1997	CA2249471A1 Tricyclic compounds having activity specific for integrins, particularly .alpha.v.beta.3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same
09/25/1997	CA2248868A1 Apoptosis inducing molecule ii
09/25/1997	CA2248843A1 Process for extraction of a growth factor complex
09/25/1997	CA2248614A1 Human cell death-associated protein
09/24/1997	EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors
09/24/1997	EP0796100A1 Combined use of diclofenac and tribenoside to treat osteoarthritis
09/24/1997	CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular.
09/24/1997	CN1160045A Matrix metalloprotease inhibitors
09/24/1997	CN1159944A 九龙接骨丸 Kowloon bone pill
09/24/1997	CN1159934A Wind-expelling and pain-alleviating drug for external use
09/24/1997	CN1159920A Powder for fracture and trauma
09/23/1997	US5670535 Thiophene compounds
09/23/1997	US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders
09/23/1997	US5670514 Benzoquinolin-3-one
09/23/1997	US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents
09/23/1997	US5670338 Genetic engineering; therapy for osteoporosis
09/18/1997	WO1997034137A2 Methods of the identification of pharmaceutically active compounds
09/18/1997	WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
09/18/1997	WO1997033995A2 Extracellular matrix signalling molecules
09/18/1997	WO1997033902A1 Human tumor necrosis factor delta and epsilon
09/18/1997	WO1997033887A1 Spirocycle integrin inhibitors
09/18/1997	WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases

1 ... 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 ... 820